GPC3 and hepatocellular carcinoma: Glypican 3 (GPC3), an oncofetal HSPG anchored to the cell membrane, exhibits elevated expression in tumor cells and tumor vascular cells in HCC, and its expression correlates with a poor prognosis (95).